LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $796,000 | -88.9% | 8,000 | -86.7% | 0.03% | -98.0% |
| Q2 2016 | $7,156,000 | -0.3% | 60,000 | -10.4% | 1.32% | +9.5% |
| Q1 2016 | $7,175,000 | -1.2% | 67,000 | 0.0% | 1.21% | +14.8% |
| Q4 2015 | $7,264,000 | +26.6% | 67,000 | 0.0% | 1.05% | +36.6% |
| Q3 2015 | $5,739,000 | +191.5% | 67,000 | +81.1% | 0.77% | +233.3% |
| Q4 2014 | $1,969,000 | +186.2% | 37,000 | +152.6% | 0.23% | +159.6% |
| Q3 2014 | $688,000 | – | 14,647 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |